National hyperlipidemia management policies improve lipid target attainment in clinical practice-Reference-Cited by-同舟云学术

National hyperlipidemia management policies improve lipid target attainment in clinical practice

Published:2017-11-08 Issue:2 Volume:34 Page:301-303
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Barkas Fotios¹^ORCID,Elisaf Moses¹^ORCID

Affiliation:

1. Department of Internal Medicine, School of Medicine, University of Ioannina, Greece

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1391082

Reference21 articles.

1. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

2. Global status report on on noncommunicable diseases. Available at: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1 [Last accessed 18 June 2017]

3. Heart Disease and Stroke Objectives. Available at: https://www.healthypeople.gov/2020/topics-objectives/topic/heart-disease-and-stroke/objectives [Last accessed 18 June 2017]

4. The “Million Hearts” Initiative — Preventing Heart Attacks and Strokes

5. Current quality of cardiovascular prevention for Million Hearts: An analysis of 147,038 outpatients from The Guideline Advantage

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-Editing Strategies for Treating Human Retinal Degenerations;Human Gene Therapy;2021-03-01

2. Hypouricaemic and nephroprotective effects of Poria cocos in hyperuricemic mice by up-regulating ATP-binding cassette super-family G member 2;Pharmaceutical Biology;2021-01-01

3. A Ketogenic & Low-Protein Diet Slows Retinal Degeneration in rd10 Mice;Translational Vision Science & Technology;2020-10-14

4. Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?;Current Vascular Pharmacology;2019-12-18

5. Enhancing the Therapeutic Potential of Mesenchymal Stem Cells with the CRISPR-Cas System;Stem Cell Reviews and Reports;2019-05-30